help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 1, 2007, doi:10.1164/rccm.200609-1362OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200609-1362OCv1
200609-1362OCv2
175/11/1181    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savale, L.
Right arrow Articles by Fartoukh, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savale, L.
Right arrow Articles by Fartoukh, M.
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 1181-1185, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200609-1362OC


Original Article

Cryptogenic Hemoptysis

From a Benign to a Life-threatening Pathologic Vascular Condition

Laurent Savale1, Antoine Parrot1, Antoine Khalil2, Martine Antoine3, Jonathan Théodore1, Marie-France Carette2, Charles Mayaud1 and Muriel Fartoukh1

1 Service de Pneumologie et Unité de Réanimation Respiratoire, 2 Service de Radiologie, and 3 Service d'Anatomie Pathologique, Hôpital Tenon, Assistance Publique–Hôpitaux de Paris and Université Pierre et Marie Curie, Paris, France

Correspondence and requests for reprints should be addressed to Muriel Fartoukh, M.D., Hôpital Tenon, Assistance Publique–Hôpitaux de Paris, 4 rue de la Chine, 75020 Paris, France. E-mail: muriel.fartoukh{at}tnn.aphp.fr

Rationale: Data on hemoptysis of unknown origin (i.e., "cryptogenic") are scarce and the outcome of patients affected is controversial.

Objectives: To describe the clinical spectrum and course of patients with cryptogenic hemoptysis, as well as pathologic findings when surgery is performed.

Methods: A cohort of 81 patients referred for cryptogenic hemoptysis after clinical evaluation, chest radiography, fiberoptic bronchoscopy, and computed tomographic scan to a respiratory intermediate care and intensive care unit, from December 1995 to August 2004, with a prospective follow-up by visit or telephone interview.

Measurements and Main Results: The 81 patients (69 males) had a mean cumulative volume of hemoptysis averaging 190 ml on admission. First-line conservative measures and bronchial artery embolization controlled hemoptysis in 73 patients (90%). Emergency surgery was performed in six patients (7%) because of failure of bronchial artery embolization, and secondary surgery was scheduled in a seventh patient. A total of 73 patients were followed for a mean of 47 (± 35) months. No lung cancer developed. Hemoptysis recurred in 10 patients (4 within the first year; 6 between 1 and 8 yr later), 2 of whom underwent surgery. A specific bronchial vascular involvement (Dieulafoy disease) was demonstrated in five of the nine patients who had undergone surgery, especially in those with high amounts of bleeding.

Conclusions: Cryptogenic hemoptysis may be a life-threatening condition. Nonsurgical approaches provide immediate control of bleeding in most patients with cryptogenic hemoptysis, with few recurrences in both short and long terms. Dieulafoy disease of the bronchus, unsuspected after routine imaging investigations, may be involved in a subset of patients yet to be determined.

Key Words: bronchial artery embolization • cryptogenic hemoptysis • Dieulafoy disease of the bronchus • management • outcome


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
There is a scarcity of available information on optimal management and outcome of cryptogenic hemoptysis.

What This Study Adds to the Field
Bleeding was controlled in most patients using a routine approach (endoscopy and bronchial artery embolization). Dieulafoy disease of the bronchus may be involved in a subset of patients.

 



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. Andrejak, A. Parrot, B. Bazelly, P. Y. Ancel, M. Djibre, A. Khalil, D. Grunenwald, and M. Fartoukh
Surgical lung resection for severe hemoptysis.
Ann. Thorac. Surg., November 1, 2009; 88(5): 1556 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Menchini, M. Remy-Jardin, J-B. Faivre, M-C. Copin, P. Ramon, R. Matran, V. Deken, A. Duhamel, and J. Remy
Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients
Eur. Respir. J., November 1, 2009; 34(5): 1031 - 1039.
[Abstract] [Full Text] [PDF]


Home page
ACCP Pulmonary Med Brd RevHome page
R. S. Irwin
Symptoms of Respiratory Disease
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 415 - 456.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  Red In Translatin